Aditxt (ADTX) announced that its board of directors has authorized management to explore taking its subsidiary, Pearsanta, public via a proposed initial public offering in 2025. Pearsanta has advanced its development and operational capabilities, particularly in early cancer detection, by leveraging its proprietary Mitomic Technology platform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADTX: